PT  - JOURNAL ARTICLE
AU  - Yeh, Ting-Yu
AU  - Contreras, Gregory P.
TI  - Full vaccination suppresses SARS-CoV-2 delta variant mutation frequency
AID  - 10.1101/2021.08.08.21261768
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.08.21261768
4099  - http://medrxiv.org/content/early/2021/08/10/2021.08.08.21261768.short
4100  - http://medrxiv.org/content/early/2021/08/10/2021.08.08.21261768.full
AB  - This study presents the first evidence that full vaccination against COVID-19 suppresses emergent mutations of SARS-CoV-2 delta variants. An evolution algorithm, Tajima’s D test with a threshold value as -2.50, can provide a promising tool to forecast new COVID-19 outbreaks.Question It remains unclear how human interventions (vaccinations, lockdowns, etc.) affect viral mutation or generate selection pressure of SARS-CoV-2. It has also been obscure if there are differences in various geographic populations.Findings The vaccination coverage rate is inversely correlated to the mutation frequency of the SARS-CoV-2 delta variants in 16 countries of 20 countries studied. We also discovered delta variants evolved differently under the positive selection pressure in the United Kingdom and India.Meaning Full vaccination against COVID-19 is critical to suppress emergent mutations. Tajima’s D test score, with a threshold value as -2.50, can provide a promising tool to forecast new COVID-19 outbreaks.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No patients were involved and no IRB was required in this study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes1.The World Health organization. Tracking SARS-CoV-2 variants. 2. Global Initiative on Sharing All Influenza Data. 3. Coronavirus (COVID-19) Vaccinations. Our World in Data. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/ https://www.gisaid.org/ https://ourworldindata.org/covid-vaccinations